摘要
经在全球基金项目中使用环丝氨酸治疗耐多药、广泛耐药肺结核患者的临床观察,及参考文献,环丝氨酸在组织耐多药、广泛耐药治疗方案时,是不可或缺、有着重要地位的一种新药,存在一定的不良反应,通过用药前评估、控制用药剂量、积极处理不良反应,可以使它安全、有效的发挥应有的作用。
After the clinical observation of using cycloserine to treat multi drug resistanceand extensively drug-resistance TB patients in the global fund projects, and references, cycloserine is an indispensible, very important new medicine in organizing multi drug resistance (extensivelydrug-resistance) therapeutic schedules. Since it has certain adverse reactions, some actionssuchas evaluation before pharmacy, controlling the medication dose, dealing with a etc; it can play a safe and effective role.
出处
《疾病监测与控制》
2015年第9期634-635,共2页
Journal of Diseases Monitor and Control
关键词
环丝氨酸
耐多药
广泛耐药的治疗
不良反应
预防评估
cyeloserine
multi drug resistance: the treatment of extensive drug resistance
adverse reaction
prevention evaluation